chemotherapy

Open Access
The Impact of Worsening Nutritional Status in Neoadjuvant Chemotherapy on Postoperative Outcomes in Esophageal Cancer
MAKOTO HASEGAWA, ZENICHIRO SAZE, HIROKI YAGO, HIROYA SUZUKI, DAI MITSUI, AKIRA MATSUISHI, YUYA MARUYAMA, HAJIME MATSUIDA, TOMOHIRO KIKUCHI, AZUMA NIREI, HIROYUKI HANAYAMA and KOJI KONO

In Vivo September 2025, 39 (5) 2842-2853; DOI: https://doi.org/10.21873/invivo.14084
Open Access
Survival and Safety Outcomes of Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma from a Single-Center Experience
AKINORI MINATO, YUI MIZUSHIMA, YOSHIHIRO SUGITA, TOMOHISA TAKABA, TAKUO MATSUKAWA, KAZUMASA JOJIMA, RIEKO KIMURO, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, EIJI KASHIWAGI and NAOHIRO FUJIMOTO

In Vivo July 2025, 39 (4) 2123-2132; DOI: https://doi.org/10.21873/invivo.14008
Open Access
Ifosfamide, Carboplatin, and Etoposide as Neoadjuvant Chemotherapy in Patients With Neurofibromatosis Type I-related Malignant Peripheral Nerve Sheath Tumors
JUNJI WASA, HIROHISA KATAGIRI, HIDEKI MURATA, SHUNICHI TOKI, KAN ITO and MITSURU TAKAHASHI

In Vivo July 2025, 39 (4) 2267-2276; DOI: https://doi.org/10.21873/invivo.14022
Open Access
Factors Contributing to Blood Glucose Elevation Associated With Olanzapine Used as an Antiemetic During Cancer Chemotherapy
YUKO KANBAYASHI, TAKESHI ISHIKAWA, TETSUYA TAGUCHI and KOICHI TAKAYAMA

In Vivo March 2025, 39 (2) 902-908; DOI: https://doi.org/10.21873/invivo.13894
Open Access
Malignant Triton Tumor of the Distal Femur: A Case Report and Review of the Literature
YOSHITAKA BAN, NAOTO OEBISU, HANA YAO, NAOKI TAKADA, MANABU HOSHI, HIROAKI NAKAMURA and KENICHI KOHASHI

In Vivo November 2024, 38 (6) 3112-3116; DOI: https://doi.org/10.21873/invivo.13796
Open Access
Real-world experience of Doxorubicin Monotherapy for Advanced or Metastatic Retroperitoneal Sarcoma: A Single Institutional Study of 16 Cases
RYO SATO, YUTO MATSUSHITA, ASUKA SANO, KYOHEI WATANABE, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, ATSUSHI OTSUKA and HIDEAKI MIYAKE

In Vivo July 2024, 38 (4) 1859-1864; DOI: https://doi.org/10.21873/invivo.13640
Open Access
Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
AKINORI MINATO, DAICHI OHNO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO

In Vivo July 2024, 38 (4) 1927-1934; DOI: https://doi.org/10.21873/invivo.13648
Open Access
Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer
MITSUKUNI SUENAGA, SHINICHI YAMAUCHI, RYO MORIKAWA, RIKA NOJI, YOSHIHITO KANO, MASANORI TOKUNAGA and YUSUKE KINUGASA

In Vivo May 2024, 38 (3) 1278-1284; DOI: https://doi.org/10.21873/invivo.13566
Open Access
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology
AKINORI MINATO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO

In Vivo March 2024, 38 (2) 873-880; DOI: https://doi.org/10.21873/invivo.13513
Open Access
[¹¹C] Methionine-PET Imaging as a Cancer Biomarker for Methionine Addiction and Sensitivity to Methionine-restriction-based Combination Chemotherapy
YUTARO KUBOTA, TOSHIHIKO SATO, QINGHONG HAN, CHIHIRO HOZUMI, SEI MORINAGA, KOHEI MIZUTA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo January 2024, 38 (1) 253-258; DOI: https://doi.org/10.21873/invivo.13432

Main menu

User menu

Search

chemotherapy

Pages